510(k) Report

510(k) · Cleared

Cleared

Global Shoulder and Delta CTA systems

K203230510(k) TraditionalCleared Apr 2, 2021151-day reviewClass II21 CFR 888.3660

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Depuy Lnc. · KWS Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented

Cleared on Apr 2, 2021 as substantially equivalent to K984541 (DePuy Orthopaedics, Inc., 1999) and 18 other predicates after a 151-day review. Its family tree reaches back 7 generations to 1980.

Decided
Apr 2, 2021
Review
151 days
Class
Class II
Product code
KWS
Recalls
None
Predicates
19

Its longest line of descent runs back 7 generations to K800494 (1980). 50 ancestors in all. No later device cites it as a predicate yet.

Other ancestors, by year cleared 2012: 1 other ancestor2009: 1 other ancestor2008: 2 other ancestors2007: 1 other ancestor2006: 3 other ancestors2005: 2 other ancestors2003: 4 other ancestors2001: 5 other ancestors2000: 2 other ancestors1999: 5 other ancestors1998: 2 other ancestors1991: 3 other ancestors2004: 2 other ancestors1994: 2 other ancestors1992: 2 other ancestors1997: 1 other ancestor1996: 1 other ancestor1995: 2 other ancestors1980: 1 other ancestor1987: 1 other ancestorK800494 · New Jersey Hemiarthroplasty Sholder Pros · Depuy, Inc. · 1980K991585 · Bipolar Shoulder Prosthesis · Biomet, Inc. · 1999K002998 · Biomet BI-Polar Shoulder System · Biomet, Inc. · 2000 · recalledK010827 · Copeland MB/HA Resurfacing Humeral Heads · Biomet Orthopedics, Inc. · 2001 · recalledK031971 · Global Cap Resurfacing Replacement Shoulder · DePuy Orthopaedics, Inc. · 2003K051843 · Copeland Eas Humeral Resurfacing Heads · Biomet, Inc. · 2005 · recalledK080990 · Depuy Global C.AP. Cta Resurfacing Shoulder · DePuy Orthopaedics, Inc. · 200819801990200020102020
  1. Root · 7 generations backK800494 New Jersey Hemiarthroplasty Sholder ProsDepuy, Inc. · 1980
  2. 6 generations backK991585 Bipolar Shoulder ProsthesisBiomet, Inc. · 1999
  3. 5 generations backK002998 Biomet BI-Polar Shoulder SystemBiomet, Inc. · 2000 · Recalled
  4. 4 generations backK010827 Copeland MB/HA Resurfacing Humeral HeadsBiomet Orthopedics, Inc. · 2001 · Recalled
  5. 3 generations backK031971 Global Cap Resurfacing Replacement ShoulderDePuy Orthopaedics, Inc. · 2003
  6. 2 generations backK051843 Copeland Eas Humeral Resurfacing HeadsBiomet, Inc. · 2005 · Recalled
  7. 1 generation backK080990 Depuy Global C.AP. Cta Resurfacing ShoulderDePuy Orthopaedics, Inc. · 2008
  8. This deviceK203230 Global Shoulder and Delta CTA systemsDepuy Lnc. · 2021
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−7K800494New Jersey Hemiarthroplasty Sholder ProsDepuy, Inc.1980—
−6K991585Bipolar Shoulder ProsthesisBiomet, Inc.1999—
−5K002998Biomet BI-Polar Shoulder SystemBiomet, Inc.20001
−4K010827Copeland MB/HA Resurfacing Humeral HeadsBiomet Orthopedics, Inc.20011
−3K031971Global Cap Resurfacing Replacement ShoulderDePuy Orthopaedics, Inc.2003—
−2K051843Copeland Eas Humeral Resurfacing HeadsBiomet, Inc.20051
−1K080990Depuy Global C.AP. Cta Resurfacing ShoulderDePuy Orthopaedics, Inc.2008—
0 (this device)K203230Global Shoulder and Delta CTA systemsDepuy Lnc.2021—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198010
198710
199130
199220
199420
199520
199610
199710
199820
199950
200020
200150
200340
200420
200520
200630
200710
200820
200910
201210
FIG. 1 — Lineage of K203230, 1980–2021Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KWS? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KWS device

  1. #1 K220847 AETOS Shoulder Systemscore 21.1 · 16 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (19)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K984541Global FX Humeral Stem, Global Advantage Humeral Head
Summary page 18
…ICE(S) Table 5- 9 Predicate Devices: Global Shoulder - GLOBAL ADVANTAGE Trade Name: GLOBAL ADVANTAGE® K984541 K992065 K000575 K011047 Global…
DePuy Orthopaedics, Inc.1999—
*K992065Global Advantage Shoulder, Global Advantage Humeral Stem, Global Advantage Eccentric Head
Summary page 18
…Table 5- 9 Predicate Devices: Global Shoulder - GLOBAL ADVANTAGE Trade Name: GLOBAL ADVANTAGE® K984541 K992065 K000575 K011047 Global…
DePuy Orthopaedics, Inc.1999—
*K000575Global Advantage Extended Humeral Head
Summary page 18
…te Devices: Global Shoulder - GLOBAL ADVANTAGE Trade Name: GLOBAL ADVANTAGE® K984541 K992065 K000575 K011047 Global Advantage…
DePuy Orthopaedics, Inc.2000—
*K011047Global Advantage Humeral Stem with Porocoat
Summary page 18
…lder - GLOBAL ADVANTAGE Trade Name: GLOBAL ADVANTAGE® K984541 K992065 K000575 K011047 Global Advantage…
DePuy Orthopaedics, Inc.2001—
*K011099Global FX Porous-Coated Humeral Stem
Summary page 19
…0 Predicate Devices: Global Shoulder - GLOBAL FX Trade Name: Global FX K984541 K011099 Global FX Porous-coated Global FX Porous-coated Device Name:…
DePuy Orthopaedics, Inc.2001—
*K033516Depuy Global Cap HA Resurfacing Shoulder Humeral Heads
Summary page 19
…0 Table 5- 11 Predicate Devices: Global Shoulder - GLOBALTM CAP Trade Name: Global CAP K033516 K080990 DePuy Global CAP™ HA…
DePuy Orthopaedics, Inc.2003—
*K080990Depuy Global C.AP. Cta Resurfacing Shoulder
Summary page 19
…- 11 Predicate Devices: Global Shoulder - GLOBALTM CAP Trade Name: Global CAP K033516 K080990 DePuy Global CAP™ HA…
DePuy Orthopaedics, Inc.2008—
*K981487Depuy Global Shoulder Glenoid
Summary page 19
…Table 5- 12 Predicate Devices: Global Shoulder - Global APG Trade Name: Global APG K981487 K052472 DePuy Global Shoulder…
DePuy Orthopaedics, Inc.1998—
*K052472Depuy Global Shoulder Crosslink Glenoid
Summary page 19
…Predicate Devices: Global Shoulder - Global APG Trade Name: Global APG K981487 K052472 DePuy Global Shoulder…
DePuy Orthopaedics, Inc.2005—
*K060874Depuy Global AP Shoulder System
Summary page 20
…Global Shoulder and Delta CTA MRI Table 5- 13 Predicate Devices: Global Shoulder - GLOBAL AP Trade Name: Global AP K060874 K063652 K082715 DePuy Global AP™ Global…
DePuy Orthopaedics, Inc.2006—
*K063652Global AP Porous Coated Humeral Stem
Summary page 20
…A MRI Table 5- 13 Predicate Devices: Global Shoulder - GLOBAL AP Trade Name: Global AP K060874 K063652 K082715 DePuy Global AP™ Global AP Porous Coated Humeral…
DePuy Orthopaedics, Inc.2007—
*K082715Depuy Global AP Cta Humeral Head
Summary page 20
…5- 13 Predicate Devices: Global Shoulder - GLOBAL AP Trade Name: Global AP K060874 K063652 K082715 DePuy Global AP™ Global AP Porous Coated Humeral DePuy Global AP CTA Device Name:…
DePuy Orthopaedics, Inc.2008—
*K092122Global Shoulder Steptech Anchor Peg Glenoid
Summary page 20
…dicate Devices: Global Shoulder – Global StepTech Trade Name: GLOBAL® STEPTECH® K092122 Global Shoulder StepTech Anchor Device…
DePuy Orthopaedics, Inc.2009—
*K914000Global (TM) Total Shoulder W/Dupont Enhanced Uhmwpe
Summary page 20
…Table 5- 15 Predicate Devices: Global Shoulder - Global Shoulder Trade Name: GLOBAL® SHOULDER K914000; K905786 K052472 Device Name Global™ Total…
Depuy, Inc.1991—
*K905786Global Total Shoulder
Summary page 20
…Table 5- 15 Predicate Devices: Global Shoulder - Global Shoulder Trade Name: GLOBAL® SHOULDER K914000; K905786 K052472 Device Name Global™ Total D…
Depuy, Inc.1991—
*K021478Delta Shoulder
Summary page 21
…and Delta CTA MRI Table 5- 16 Predicate Devices: DELTA CTATM Trade Name: DELTA CTA; IFU: W90926 and W90916 K021478 K050315 K062116 K122442…
Depuy, Inc.2003—
*K050315Delta Humeral Cups
Summary page 21
…Table 5- 16 Predicate Devices: DELTA CTATM Trade Name: DELTA CTA; IFU: W90926 and W90916 K021478 K050315 K062116 K122442 Delta Rev…
DePuy Orthopaedics, Inc.2005—
*K062116Delta Cta Reverse Shoulder System Humeral Heads
Summary page 21
…Table 5- 16 Predicate Devices: DELTA CTATM Trade Name: DELTA CTA; IFU: W90926 and W90916 K021478 K050315 K062116 K122442 Delta Reverse…
DePuy Orthopaedics, Inc.2006—
*K122442Depuy Cta Reverse Shoulder System
Summary page 21
…Devices: DELTA CTATM Trade Name: DELTA CTA; IFU: W90926 and W90916 K021478 K050315 K062116 K122442 Delta Reverse…
Depuy France2012—

Also cleared against K984541: 9 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 41 years and passes through 5 companies; a new generation was cleared every 2.0 years on median.
  • 12 of the 50 ancestors have a recall of any class.
  • 9 other devices also cite its predicate K984541.

How does its category compare?

All KWS devices

KWS Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented: FDA decisions, review times, recalls and adverse event reports over 20 years. 2021, this device’s year, is highlighted.

FDA decisions per year · KWS

3in 2025

2007: 22008: 42009: 42010: 72011: 112012: 72013: 122014: 72015: 82016: 102017: 72018: 42019: 92020: 32021: 52022: 52023: 42024: 22025: 32026 (partial year): 2
2007high 12 (2013) · low 2 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KWS

97in 2025

2008: 37 days median2009: 108 days median2010: 33 days median2011: 90 days median2012: 86 days median2013: 120 days median2014: 89 days median2015: 129 days median2016: 114 days median2017: 120 days median2018: 152 days median2019: 106 days median2020: 98 days median2021: 151 days median2022: 158 days median2023: 250 days median2025: 97 days median
2007high 250 (2023) · low 33 (2010)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KWS

2in 2023

2007: 212008: 292010: 102011: 112012: 102014: 12016: 12017: 42018: 12019: 22020: 52023: 22026 (partial year): 1
2007high 29 (2008) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KWS

2,281in 2025

2007: 1582008: 2382009: 2942010: 3932011: 4862012: 5422013: 8182014: 1,0662015: 1,1702016: 9702017: 1,6812018: 1,5452019: 1,7282020: 1,5672021: 1,3582022: 1,2682023: 1,7502024: 2,1222025: 2,281
2007high 2,281 (2025) · low 158 (2007)2025

MAUDE reports naming product code KWS, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—21158
200843729238
200941080294
201073310393
2011119011486
201278610542
2013121200818
201478911,066
2015812901,170
2016101141970
2017712041,681
2018415211,545
2019910621,728
202039851,567
2021515101,358
2022515801,268
2023425021,750
20242—02,122
202539702,281
20262—1—

What is it indicated for?

The DePuy GLOBAL ADVANTAGE Shoulder Systems The DePuy GLOBAL ADVANTAGE Shoulder Systems is indicated for use in total or hemi-shoulder replacement for the treatment of: 1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis; 2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience…

Read the full statement (1,288 words)

The DePuy GLOBAL ADVANTAGE Shoulder Systems

The DePuy GLOBAL ADVANTAGE Shoulder Systems is indicated for use in total or hemi-shoulder replacement for the treatment of:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis;

2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory;

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g. revision of a failed primary component).

The DePuy GLOBAL ADVANTAGE Shoulder System is also indicated for hemi-shoulder replacement for the treatment of:

1. Ununited humeral head fractures;

2. Avascular necrosis of the humeral head.

GLOBAL ADVANTAGE CTA Humeral Heads

The DePuy GLOBAL ADVANTAGE CTA Humeral Heads are indicated only for hemi-shoulder replacement in patients with rotator cuff tears.

The DePuy GLOBAL ADVANTAGE CTA Humeral Heads can be used with the GLOBAL FX and GLOBAL ADVANTAGE Humeral Stems in hemi-shoulder replacement in patients with rotator cuff tears.

GLOBAL ADVANTAGE Shoulder Systems Fixation Methods

The DePuy GLOBAL ADVANTAGE Systems are indicated for the following fixation methods:

POROCOAT™ Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating.

Cemented Components - Humeral Stem and Glenoid components labeled "For cemented use only" are indicated only for use with bone cement.

Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled "For press-fit or cemented use only" are indicated for press-fit uncemented use or for use with bone cement.

The DePuy GLOBAL FX Shoulder System is indicated only for hemi-shoulder replacement for the treatment of:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis;

2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory;

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g. revision of a failed primary component);

4. Ununited humeral head fractures;

5. Avascular necrosis of the humeral head.

GLOBAL FX Shoulder Systems Fixation Methods

The DePuy GLOBAL FX Shoulder System is indicated for the following fixation methods:

• POROCOAT™ Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating.

• Cemented Components - Humeral Stem and Glenoid components labeled “For cemented use only” are indicated only for use with bone cement.

• Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled “For press-fit or cemented use only” are indicated for press-fit uncemented use or for use with bone cement.

GLOBAL™ CAP

The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are intended as a total or hemi-shoulder replacement in patients where the humeral head and neck are of sufficient bone stock and the rotator cuff is intact or reconstructable. This device is designed to increase shoulder mobility by: reducing pain; restoring alignment; restoring flexion and extension movement; and resisting dislocation.

The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are indicated for use as a replacement of shoulder joints disabled by rheumatoid arthritis with pain, non-inflammatory degenerative joint disease (i.e. osteoarthritis and avascular necrosis), deformity and/or limited motion, fractures of the humeral head and traumatic arthritis.

The DePuy GLOBAL™ CAP Resurfacing Shoulder Humeral Heads are intended for uncemented use only.

GLOBAL™ CAP CTA™

The DePuy GLOBAL ™ CAP CTA Resurfacing Shoulder is indicated only for hemi-shoulder replacement in patients with rotator cuff tears and arthritis. Specific indications include:

1. Rotator cuff tear arthropathy.

2. Difficult clinical management problems where other methods of treatment may not be suitable or may be inadequate.

The DePuy GLOBAL ™CAP CTA Resurfacing Shoulder Humeral Heads are intended for uncemented use only.

The Glenoid is intended for use in total shoulder replacement surgery for patients suffering from:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis

2. Fracture-dislocations of the proximal humerus where the articular surface is severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory.

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g revision of a failed primary component).

Glenoid components are intended for cemented use only.

The DePuy GLOBAL AP Shoulder System

The DePuy GLOBAL AP Shoulder System is indicated for use in total or hemi-shoulder replacement for the treatment of:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis;

2. Fracture-dislocations of the proximal humerus where the articular surface is severely comminuted, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory;

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g. revision of a failed primary component).

The DePuy GLOBAL AP Shoulder Systems is also indicated for hemi-shoulder replacement for the treatment of:

1. Ununited humeral head fractures;

2. Avascular necrosis of the humeral head.

GLOBAL AP™ CTA Humeral Heads

The DePuy GLOBAL AP CTA Humeral Heads are indicated only for hemi-shoulder replacement in patients with rotator cuff tears.

The GLOBAL AP CTA Humeral Head can be used with the GLOBAL AP Humeral Stem in hemi-shoulder replacement in patients with rotator cuff tears.

GLOBAL AP™ Shoulder Systems Fixation Methods

The DePuy GLOBAL AP Shoulder Systems are indicated for the following fixation methods:

POROCOAT™ Porous-Coated Components - Porocoat porous-coated humeral stem prostheses are indicated for cemented or uncemented use with fixation provided by biological tissue ingrowth into the porous coating.

Cemented Components - Humeral Stem and Glenoid components labeled "For cemented use only" are indicated only for use with bone cement.

Press-fit or Cemented Components - Humeral stem prostheses without porous coating and labeled "For press-fit or cemented use only" are indicated for press-fit uncemented use or for use with bone cement.

The StepTech Anchor Peg Glenoid is intended for use in total shoulder replacement surgery for patients suffering from:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis

2. Fracture-dislocations of the proximal humerus where the articular surface is severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory.

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g revision of a failed primary component).

Glenoid components are intended for cemented use only.

The Glenoid is intended for use in total shoulder replacement surgery for patients suffering from:

1. A severely painful and/or disabled joint resulting from osteoarthritis, traumatic arthritis or rheumatoid arthritis

2. Fracture-dislocations of the proximal humerus where the articular surfaces are severely communited, separated from its blood supply or where the surgeon's experience indicates that alternative methods of treatment are unsatisfactory.

3. Other difficult clinical problems where shoulder arthrodesis or resection arthroplasty are not acceptable (e.g. revision of a failed primary component).

Glenoid components are intended for cemented use only.

The DELTA CTATM Reverse Shoulder Prosthesis is indicated for use in:

1. Grossly rotator cuff deficient joint with severe arthropathy or a previous failed joint replacement with a grossly rotator cuff deficient joint.

2. The DELTA CTATM hemi-shoulder replacement is also indicated for hemi-arthroplasty if the glenoid is fractured intraoperatively or for revision surgery in cases with insufficient glenoid bone stock.

3. The patient's joint must be anatomically and structurally suited to receive the selected implant(s), and a functional Deltoid muscle is necessary to use the device.

For US use only: All components are intended for cemented use only

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K203230: Global Shoulder and Delta CTA systems.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K203230

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026